The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Bath salts and synthetic cathinones: An emerging designer drug phenomenon
Open accessAbstract
The synthetic cathinones are an emerging class of designer drugs abused for psychostimulant and hallucinogenic effects similar to cocaine, methylenedioxymethamphetamine (MDMA), or other amphetamines. Abuse of synthetic cathinones, frequently included in products sold as ‘bath salts’, became prevalent in early 2009, leading to legislative classification throughout Europe in 2010 and schedule I classification within the United States in 2011. Recent pre-clinical and clinical studies indicate dysregulation of central monoamine systems are a principal mechanism of synthetic cathinone action and presumably underlie the behavioral effects and abuse liability associated with these drugs. This review provides insight into the development of synthetic cathinones as substances of abuse, current patterns of their abuse, known mechanisms of their action and toxicology, and the benefits and drawbacks of their classification.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The expanded biology of serotonin
Berger, M., Gray, J. A., & Roth, B. L. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.042307.110802 · Cited by 2,100 · cited 2×
“Peripheral monoamines, particularly norepinephrine (NE) and 5-HT, are important regulators of autonomic nervous system function (for review, see (Berger et al., 2009)) and disruption of these systems by stimulants frequently coincides with profound changes in peripheral organ systems, such as the cardiovascular and di…”
New Insights into the Mechanism of Action of Amphetamines
Fleckenstein, A. E., Volz, T. J., Riddle, E. L., Gibb, J. W., & Hanson, G. R. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105140 · Cited by 731
Self-citationSpiller, H. A., Ryan, M. L., Weston, R. G., & Jansen, J. (2011) · Clinical Toxicology · doi:10.3109/15563650.2011.590812 · Cited by 522
LaVoie, M. J., & Hastings, T. G. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-04-01484.1999 · Cited by 447
Baumann, M. H., Ayestas, M. A., Partilla, J. S., Sink, J. R., Shulgin, A. T., Daley, P. F., Brandt, S. D., Rothman, R. B., Ruoho, A. E., & Cozzi, N. V. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.304 · Cited by 439
Baumann, M. H., Partilla, J. S., Lehner, K. R., Thorndike, E. B., Hoffman, A. F., Holy, M., Rothman, R. B., Goldberg, S. R., Lupica, C. R., Sitte, H. H., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.204 · Cited by 408
Kehr, J., Ichinose, F., Yoshitake, S., Goiny, M., Sievertsson, T., Nyberg, F., & Yoshitake, T. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01499.x · Cited by 312
Mephedrone: use, subjective effects and health risks: Mephedrone and health risks
Winstock, A., Mitcheson, L., Ramsey, J., Davies, S., Puchnarewicz, M., & Marsden, J. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03502.x · Cited by 273
The neuroleptic malignant syndrome: agent and host interaction
Shalev, A., & Munitz, H. (1986) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1986.tb02694.x · Cited by 261
A web-based survey on mephedrone
Carhart-Harris, R. L., King, L. A., & Nutt, D. J. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.02.011 · Cited by 244
Dargan, P. I., Albert, S., & Wood, D. M. (2010) · QJM · doi:10.1093/qjmed/hcq134 · Cited by 242
4-Methylmethcathinone (Mephedrone): Neuropharmacological Effects of a Designer Stimulant of Abuse
Hadlock, G. C., Webb, K. M., McFadden, L. M., Chu, P. W., Ellis, J. D., Allen, S. C., Andrenyak, D. M., Vieira-Brock, P. L., German, C. L., Conrad, K. M., et al. (2011) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.184119 · Cited by 242
Self-citationAmphetamine induces dopamine efflux through a dopamine transporter channel
Kahlig, K. M., Binda, F., Khoshbouei, H., Blakely, R. D., McMahon, D. G., Javitch, J. A., & Galli, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407737102 · Cited by 239
Borek, H. A., & Holstege, C. P. (2012) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2012.01.005 · Cited by 223
Instability of the ecstasy market and a new kid on the block: mephedrone
Brunt, T. M., Poortman, A., Niesink, R. J., & van den Brink, W. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110378370 · Cited by 215
James, D., Adams, R. D., Spears, R., Cooper, G., Lupton, D. J., Thompson, J. P., Thomas, S. H. L., & Service, O. B. O. T. N. P. I. (2011) · Emergency Medicine Journal · doi:10.1136/emj.2010.096636 · Cited by 214
Marinetti, L. J., & Antonides, H. M. (2013) · Journal of Analytical Toxicology · doi:10.1093/jat/bks136 · Cited by 213
Purchasing 'legal highs' on the Internet--is there consistency in what you get?
Davies, S., Wood, D. M., Smith, G., Button, J., Ramsey, J., Archer, R., Holt, D. W., & Dargan, P. I. (2010) · QJM · doi:10.1093/qjmed/hcq056 · Cited by 212
The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents*
Freudenmann, R. W., Öxler, F., & Bernschneider‐Reif, S. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01511.x · Cited by 199
López‐Arnau, R., Martínez‐Clemente, J., Pubill, D., Escubedo, E., & Camarasa, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01998.x · Cited by 196
Designer Drugs: Past History and Future Prospects
Henderson, G. (1988) · Journal of Forensic Sciences · doi:10.1520/jfs11976j · Cited by 191
Mephedrone (4-Methylmethcathinone)-Related Deaths
Maskell, P. D., De Paoli, G., Seneviratne, C., & Pounder, D. J. (2011) · Journal of Analytical Toxicology · doi:10.1093/anatox/35.3.188 · Cited by 179
Watterson, L. R., Kufahl, P. R., Nemirovsky, N. E., Sewalia, K., Grabenauer, M., Thomas, B. F., Marusich, J. A., Wegner, S., & Olive, M. F. (2014) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00474.x · Cited by 176
Relationship Between the Discriminative Stimulus Properties and Subjective Effects of Drugs
Schuster, C. R., & Johanson, C. E. (1988) · Transduction Mechanisms of Drug Stimuli · doi:10.1007/978-3-642-73223-2_13 · Cited by 175
Fantegrossi, W. E., Gannon, B. M., Zimmerman, S. M., & Rice, K. C. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.233 · Cited by 152
Psychoactive "bath salts" intoxication with methylenedioxypyrovalerone.
Ross, E., Reisfield, G., Watson, M., Chronister, C. W., & Goldberger, B. (2012) · American Journal of Medicine · doi:10.1016/j.amjmed.2012.02.019 · Cited by 143
Cognitive and subjective effects of mephedrone and factors influencing use of a ‘new legal high’
Freeman, T. P., Morgan, C. J. A., Vaughn‐Jones, J., Hussain, N., Karimi, K., & Curran, H. V. (2012) · Addiction · doi:10.1111/j.1360-0443.2011.03719.x · Cited by 136
Khat in the Horn of Africa: Historical perspectives and current trends
Gebissa, E. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.01.063 · Cited by 134
Interaction of mephedrone with dopamine and serotonin targets in rats
Martínez-Clemente, J., Escubedo, E., Pubill, D., & Camarasa, J. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.009 · Cited by 128
Schifano, F., Corkery, J., & Ghodse, A. H. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318266c70c · Cited by 120
Lisek, R., Xu, W., Yuvasheva, E., Chiu, Y.-T., Reitz, A. B., Liu‐Chen, L., & Rawls, S. M. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.04.021 · Cited by 120
Long-term cognitive and neurochemical effects of “bath salt” designer drugs methylone and mephedrone
den Hollander, B., Rozov, S. V., Linden, A.-M., Uusi‐Oukari, M., Ojanperä, I. A., & Korpi, E. R. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.10.006 · Cited by 113
Angoa‐Pérez, M., Kane, M. J., Francescutti, D. M., Sykes, K. E., Shah, M. M., Mohammed, A. M., Thomas, D. M., & Kuhn, D. M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07632.x · Cited by 109
Cameron, K. N., Kolanoś, R., Solis, E., Glennon, R. A., & DeFelice, L. J. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12061 · Cited by 108
Miller, M. L., Creehan, K. M., Angrish, D., Barlow, D. J., Houseknecht, K. L., Dickerson, T. J., & Taffe, M. A. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.07.003 · Cited by 100
Bowyer, J. F., Robinson, B. L., Ali, S. F., & Schmued, L. C. (2007) · Synapse · doi:10.1002/syn.20478 · Cited by 97
Thornton, S. L., Gerona, R. R. L., & Tomaszewski, C. (2012) · Journal of Medical Toxicology · doi:10.1007/s13181-012-0232-4 · Cited by 93
Wright, M. J., Angrish, D., Aarde, S. M., Barlow, D. J., Buczynski, M. W., Creehan, K. M., Vandewater, S. A., Parsons, L. H., Houseknecht, K. L., Dickerson, T. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044652 · Cited by 93
Shortall, S. E., Macerola, A. E., Swaby, R., Jayson, R., Korsah, C., Pillidge, K., Wigmore, P. M., Ebling, F. J. P., Green, A. R., Fone, K. C. F., et al. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.09.005 · Cited by 87
Fleckenstein, A. E., Wilkins, D. G., Gibb, J. W., & Hanson, G. R. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37016-8 · Cited by 84
Self-citationRecurrent Acute Kidney Injury Following Bath Salts Intoxication
Adebamiro, A., & Perazella, M. A. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.10.012 · Cited by 81
Oxygen radicals diminish dopamine transporter function in rat striatum
Fleckenstein, A. E., Metzger, R. R., Beyeler, M. L., Gibb, J. W., & Hanson, G. R. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01175-8 · Cited by 78
Self-citationKasick, D. P., McKnight, C. A., & Klisovic, E. S. (2012) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2011.643999 · Cited by 78
Methcathinone: A russian designer amphetamine infiltrates the rural midwest
Emerson, T. S., & Cisek, J. (1993) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(05)80419-6 · Cited by 76
Angoa‐Pérez, M., Kane, M. J., Briggs, D. I., Francescutti, D. M., Sykes, C. E., Shah, M. M., Thomas, D. M., & Kuhn, D. M. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12114 · Cited by 74
Cathinone, an alkaloid from khat leaves with an amphetamine-like releasing effect
Kalix, P. (1981) · Psychopharmacology · doi:10.1007/bf00427108 · Cited by 70
Mephedrone in Adolescent Rats: Residual Memory Impairment and Acute but Not Lasting 5-HT Depletion
Motbey, C. P., Karanges, E. A., Li, K. M., Wilkinson, S. M., WINSTOCK, A. R., Ramsay, J., Hicks, C., Kendig, M. D., Wyatt, N. A., Callaghan, P. D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045473 · Cited by 64
Robinson, J. E., Agoglia, A. E., Fish, E. W., Krouse, M. C., & Malanga, C. J. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.06.012 · Cited by 64
The Toxicology Investigators Consortium Case Registry—The 2011 Experience
Wiegand, T. J., Wax, P. M., Schwartz, T. M., Finkelstein, Y., Gorodetsky, R. M., & Brent, J. A. (2012) · Journal of Medical Toxicology · doi:10.1007/s13181-012-0264-9 · Cited by 58
Clinical Toxicology and Management of Intoxications With Synthetic Cathinones (“Bath Salts”)
Mas-Morey, P., Visser, M., Mitrov‐Winkelmolen, L., & Touw, D. J. (2012) · Journal of Pharmacy Practice · doi:10.1177/0897190012465949 · Cited by 57
Behind the identification of China White
Kram, T. C., Cooper, D. A., & Allen, A. C. (1981) · Analytical Chemistry · doi:10.1021/ac00235a003 · Cited by 56
New “Lethal highs”: A case of a deadly cocktail of GHB and Mephedrone
Aromatario, M., Bottoni, E., Santoni, M., & Ciallella, C. (2012) · Forensic Science International · doi:10.1016/j.forsciint.2012.09.014 · Cited by 55
Khat in the Horn of Africa: Historical perspectives and current trends
Gebissa, Z. (2010) · Cited by 46
Variability in the 3,4-methylenedioxymethamphetamine content of 'ecstasy' tablets in the UK
Wood, D. M., Stribley, V., Dargan, P. I., Davies, S., Holt, D. W., & Ramsey, J. (2010) · Emergency Medicine Journal · doi:10.1136/emj.2010.092270 · Cited by 40
Wright, M. J., Vandewater, S., Angrish, D., Dickerson, T., & Taffe, M. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02091.x · Cited by 39
A Growing Industry and Menace: Makeshift Laboratory's Designer Drugs
Ziporyn, T. D. (1986) · JAMA · doi:10.1001/jama.1986.03380220011003 · Cited by 25
Connor, C. E., & Kuczenski, R. T. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90396-5 · Cited by 22
Risperidone reduction of amphetamine-induced self-injurious behavior in mice
Wagner, G. C., Avena, N., Kita, T., Nakashima, T., Fisher, H., & Halladay, A. K. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.11.009 · Cited by 22
Adolescent Synthetic Cathinone Exposures Reported to Texas Poison Centers
Forrester, M. B. (2013) · Pediatric Emergency Care · doi:10.1097/pec.0b013e3182808ae2 · Cited by 16
Cited by
New psychoactive substances: a review and updates
Shafi, A., Berry, A. J., Sumnall, H., Wood, D. M., & Tracy, D. K. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320967197 · Cited by 347
Why Are the Majority of Active Compounds in the CNS Domain Natural Products? A Critical Analysis
Bharate, S. S., Mignani, S., & Vishwakarma, R. A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01922 · Cited by 102
Applications and potential of in silico approaches for psychedelic chemistry
Karabulut, S., Kaur, H., & Gauld, J. W. (2023) · Molecules · doi:10.3390/molecules28165966 · Cited by 8
Metadata
- Authors
- German, C. L., Fleckenstein, A. E., & Hanson, G. R.
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 97
- Issue
- 1
- Pages
- 2-8
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W2014953635
- Cited by
- 348
- References
- 59
- FWCI
- 33.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.